SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 51.11-2.1%Nov 13 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: A.J. Mullen who wrote (7726)1/15/2003 11:44:11 AM
From: Biomaven  Read Replies (2) of 52153
 
The moratorium appears to be on using "retroviral vectors to insert genes into blood stem cells." But of course with a retroviral vector I'm not sure you can easily limit where the gene ends up.

Off the top of my head because I don't follow gene therapy much at all, I would guess that they are concerned that this is a reaction to the vector itself, or at least the vector/payload combination. I would further guess that naked DNA is inherently "cleaner."

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News